VanEck Associates’s Advent Technologies ADN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,791
Closed -$216K 1402
2023
Q1
$216K Buy
6,791
+1,122
+20% +$56.6K ﹤0.01% 1153
2022
Q4
$308K Buy
5,669
+1,077
+23% +$66.7K ﹤0.01% 1006
2022
Q3
$422K Buy
+4,592
New +$409K ﹤0.01% 914
2022
Q2
Sell
-2,946
Closed -$205K 1371
2022
Q1
$205K Buy
2,946
+141
+5% +$16K ﹤0.01% 1091
2021
Q4
$590K Buy
2,805
+791
+39% +$197K ﹤0.01% 931
2021
Q3
$526K Buy
2,014
+1,191
+145% +$290K ﹤0.01% 905
2021
Q2
$238K Buy
+823
New +$274K ﹤0.01% 984

Other funds holding ADN

VanEck Associates's ADN Position: Q2 2023 in Review

VanEck Associates sold out of Advent Technologies (ADN) in Q2 2023, closing a stake of 6,791 shares — an estimated $216K sold.

VanEck Associates first reported a position in ADN in Q2 2021 and held it in 7 quarters. The position peaked at $590K in Q4 2021. 34 funds tracked by Wall St. Rank hold ADN as of Q2 2023.

  • VanEck Associates reported no remaining Advent Technologies position as of Q2 2023 after selling out during the quarter.
  • VanEck Associates sold 6,791 Advent Technologies shares in Q2 2023, an estimated $216K.
  • VanEck Associates first reported a position in Advent Technologies in Q2 2021 and held it in 7 quarters.
  • VanEck Associates's Advent Technologies position peaked at $590K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Advent Technologies as of Q2 2023.

Based on VanEck Associates's 13F filing for Q2 2023, filed 3 Aug 2023.